Is Adynxx, Inc. (ADYX) a Buy, Sell, or Hold?
OTC : ADYX
Adynxx, Inc.
$0.0001 USD
$0 (0.0%)
- Volume
- 16.3K
- Average Volume
- 15.03K
- Market Capitalization
- $581
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $6.76
Company Overview
OTC
Richard Orr
Biotechnology
Healthcare
ADYX
6
US
USD
Liquidity Metrics
0.00
6.76
6.69
6.45
0.00
Sales & Valuation
$2.22M
0.00
0.00
0.00
-11.83
Profitability
-$10.26
-$8.42M
-379.83%
-316.06%
-70.38%
-86.96%
P/E Metrics
0.00
0.00
0.00
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
-30.38
2/9
-$11.25M
$3.25M
$14.32M
-$6.4M
Key Metrics (TTM)
-$8.87M
-4.00
2.60
6.76
-70.38%
-63.78%
-10257566.43%
-1671256.45%
-93 days
Company Executives
| Name | Title |
|---|---|
| Richard Orr | President, Chief Executive Officer, Principal Financial Officer & Director |
| William Martin | Executive Vice President of Corporate Development & Operations |
| Dina Gonzalez | Principal Accounting Officer & Senior Vice President of Finance |
| Kimberley Hebert | Senior Director of Clinical Operations |
Poll Results
No votes yet today — be the first to share your view!
About Adynxx, Inc. (OTC:ADYX) Stock
Adynxx, Inc. is a clinical-stage biopharmaceutical firm dedicated to creating and commercializing novel transcription factor decoy technologies to combat pain and inflammatory conditions. Central to its efforts is the AYX platform of transcription factor decoys, which includes brivoligide, currently progressing through Phase II clinical development for reducing post-surgical discomfort. Additionally, AYX2 is a pre-clinical candidate being explored for its potential in treating localized chronic pain. Established in 2007, the company's corporate headquarters are situated in San Francisco, California. ...
Frequently Asked Questions
-
What is the current Adynxx, Inc. (ADYX) stock price?
-
Adynxx, Inc.(OTC:ADYX) stock price is $0.0001 in the last trading session. During the trading session, ADYX stock reached the peak price of $0.0002 while $0.0001 was the lowest point it dropped to. The percentage change in ADYX stock occurred in the recent session was 0.0% while the dollar amount for the price change in ADYX stock was $0.
-
ADYX's industry and sector of operation?
-
The OTC listed ADYX is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of ADYX?
-
Richard Orr | President, Chief Executive Officer, Principal Financial Officer & Director
William Martin | Executive Vice President of Corporate Development & Operations
Dina Gonzalez | Principal Accounting Officer & Senior Vice President of Finance
Kimberley Hebert | Senior Director of Clinical Operations
| -
How many employees does ADYX have?
-
Number of ADYX employees currently stands at 6. ADYX operates from 100 Pine Street, San Francisco, CA 94111, US.
-
Link for ADYX official website?
-
Official Website of ADYX is: https://www.adynxx.com
-
How do I contact ADYX?
-
ADYX could be contacted at phone #415-512-7740 and can also be accessed through its website. ADYX operates from 100 Pine Street, San Francisco, CA 94111, US.
-
How many shares of ADYX are traded daily?
-
The average number of ADYX shares traded daily for last 3 months was 15.03K.
-
What is the market cap of ADYX currently?
-
The market value of ADYX currently stands at $581 with its latest stock price at $0.0001